NeuroMetrix, Inc. (Nasdaq:NURO) plans to issue its 2012 second quarter financial results before the opening of the market on July 26, 2012. The Company will host a conference call at 8:00 a.m., Eastern Time on July 26, 2012 to discuss its second quarter financial results as well as business developments affecting the Company.
The most important advantage of video marketing is that it is simpler to create videos than creating original convincing text and videos definitely help to engage the visitors far better than articles do.
Crown Equity Holdings Inc., (CRWE) recenly launched CRWE Tube, www.crwetube.com, a video sharing site that allows billions of people around the world to upload, watch and share original videos.
CRWE offers advertising branding and marketing services as a worldwide online multi-media publisher with its digital network of websites and focuses on the distribution of information for the purpose of bringing together a targeted audience and the advertisers that want to reach them.
CRWEs advertising services cover and connect a range of marketing specialties, as well as provide search engine optimization for clients interested in online media awareness.
More about CRWE at www.crownequityholdings.com.
Stanley Black & Decker (NYSE:SWK) reported that its Board of Directors approved a 20% increase of its quarterly cash dividend to $0.49 per common share. This marks the 45th consecutive annual dividend increase for the company.
The dividend is payable on Tuesday, September 18, 2012 to shareholders of record as of the close of business on Friday, September 7, 2012.
The Board of Directors also approved a new share repurchase program of up to 20 million shares of the companys common stock, or $1.2 billion, using the current stock price. Repurchases will be made in accordance with applicable securities laws from time to time in open market or private transactions, depending on market conditions, and may be discontinued at any time.
Dr. Reddys Laboratories (NYSE:RDY) reported that it has launched ATORVASTATIN CALCIUM TABLETS 10 mg, 20 mg, 40 mg and 80 mg, a bioequivalent generic version of LIPITOR(R) (atorvastatin calcium) tablets, in the US market on July 17, 2012 following the approval by the United States Food & Drug Administration (USFDA) of Dr. Reddys ANDA for atorvastatin calcium tablets.
The LIPITOR(R) brand had U.S. sales of approximately $8.07 billion for the most recent twelve months ending March 2012 according to IMS Health.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. BestOtc.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer ( http://bestotc.com/disclaimer) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold BestOTC.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE) advertises for a particular client, Crown Equity Holdings Inc. (CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE), if paid in stock, can and may sell those securities during the advertising period.